# PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.

> **NCT01664221** · PHASE1 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 80 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT01664221
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664221, "PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01664221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*